Insurance underwriting restrictions on genetics

Introduction

Insurance underwriting restrictions on genetics refer to legal, regulatory, and contractual limitations imposed on insurance companies when using an individual's genetic information to evaluate insurance applications, determine premiums, impose exclusions, or reject coverage. Advances in genetic testing and biotechnology have enabled the identification of genetic variations associated with inherited diseases, medical conditions, and potential health risks.

Genetic information may reveal an individual's susceptibility to conditions such as hereditary cancers, cardiovascular disorders, neurological diseases, and metabolic disorders. Although this information can assist medical professionals in preventive healthcare, its use by insurance companies creates concerns regarding genetic discrimination, privacy, equality, and access to financial protection.

Insurance companies traditionally evaluate applicants through medical history, family medical background, lifestyle information, and other underwriting factors. However, genetic testing introduces a new challenge because a person may possess a genetic predisposition without ever developing the associated disease.

Consequently, underwriting restrictions are necessary to prevent insurers from treating genetic susceptibility as conclusive evidence of future illness. These restrictions aim to balance legitimate insurance risk assessment with individual privacy, fairness, and protection against discrimination.

Meaning and nature of genetic underwriting

Genetic underwriting refers to the process through which insurance companies evaluate genetic information while determining an individual's eligibility for insurance coverage and calculating financial risk.

Genetic information may include:

Results of genetic screening and diagnostic tests.

Information concerning inherited genetic mutations.

Family history of hereditary diseases.

Genetic susceptibility to particular medical conditions.

Information obtained through genomic sequencing.

Predictive genetic information concerning future health risks.

A distinction must be maintained between diagnostic genetic testing and predictive genetic testing. Diagnostic testing identifies or helps confirm an existing medical condition, whereas predictive testing estimates the possibility of developing a condition in the future.

This distinction is important because genetic susceptibility does not necessarily mean that an individual will develop a particular disease.

Major underwriting restrictions on genetics

1. Restrictions on compulsory genetic testing

Insurance companies may face legal and regulatory limitations concerning requests for genetic testing.

Compulsory genetic testing can interfere with personal autonomy and privacy, particularly where testing is not medically necessary for the insurance application.

A fair underwriting framework should prevent unnecessary demands for genetic testing and ensure that information is collected only on a lawful and justified basis.

2. Restrictions on genetic discrimination

Insurers should not automatically classify individuals as uninsurable merely because they possess a genetic variation associated with a particular disease.

For example, an individual carrying a hereditary cancer-associated mutation may never develop cancer.

Using such information without reliable actuarial and medical justification may result in unfair discrimination.

3. Restrictions on premium determination

Genetic information may influence an insurer's assessment of future medical risks.

However, insurers should distinguish between scientifically established medical risks and uncertain genetic predictions.

Premium decisions should comply with applicable insurance regulations, contractual requirements, and relevant anti-discrimination protections.

4. Restrictions on disclosure of genetic information

Genetic information is highly sensitive because it may reveal details about biological relationships and inherited medical conditions.

Insurance companies must comply with applicable data protection requirements when collecting, storing, processing, and sharing such information.

5. Restrictions on genetic information obtained from family members

Genetic information about one individual may reveal potential inherited risks concerning biological relatives.

Insurers must carefully consider privacy and lawful processing requirements before using information relating to family members who are not parties to the insurance contract.

6. Restrictions on automated genetic underwriting

Artificial intelligence systems may analyse genetic information alongside medical and lifestyle records to calculate insurance risks.

However, inaccurate genetic datasets or discriminatory algorithms may produce unfair underwriting outcomes.

Insurers should ensure appropriate oversight, transparency, and reliability in automated decision-making.

Legal framework governing genetic underwriting in India

India does not currently have a comprehensive standalone law specifically prohibiting the use of genetic information in insurance underwriting. However, several existing legal frameworks provide relevant protections.

1. Article 14 of the Constitution

Article 14 guarantees equality before the law and equal protection of the laws.

Arbitrary discrimination based on genetic characteristics may raise constitutional concerns, particularly where public authorities or state-controlled entities are involved.

2. Article 21 of the Constitution

Article 21 protects life and personal liberty, including the fundamental right to privacy.

Genetic information forms an important part of personal medical privacy. The collection and use of such information by insurers must therefore be considered in light of constitutional privacy principles and applicable legislation.

3. Digital Personal Data Protection Act, 2023

The Act establishes requirements governing the processing of digital personal data.

Genetic information stored or processed digitally may fall within its scope. Its provisions concerning lawful processing, consent, notice, security safeguards, and individual rights are relevant to insurance underwriting.

However, the Act does not establish a separate statutory category of genetic data.

4. Insurance Act, 1938

The Insurance Act provides the statutory foundation for insurance regulation in India.

It establishes the broader regulatory framework within which insurers conduct insurance business and assess risks.

5. IRDAI regulatory framework

IRDAI regulates insurance products and policyholder protection. Its regulatory requirements concerning transparency, fair treatment, policy disclosures, and claim settlement are relevant when insurers use genetic information in underwriting decisions.

6. Consumer Protection Act, 2019

The Act provides remedies against deficiencies in insurance services and unfair trade practices.

An applicant or policyholder may seek appropriate remedies where an insurer engages in legally actionable unfair practices involving genetic information.

Important case laws

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court of India recognised privacy as a fundamental right under Article 21 of the Constitution.

Legal significance: The judgment provides an important constitutional foundation for protecting genetic information. Since genetic data may reveal highly personal medical and biological characteristics, its collection and processing by insurance companies must respect applicable privacy protections.

2. Selvi v. State of Karnataka (2010)

The Supreme Court examined the constitutional validity of involuntary scientific techniques, including brain electrical activation profile tests, narcoanalysis, and polygraph examinations.

Legal significance: The judgment recognised the importance of personal autonomy, mental privacy, and protection against involuntary extraction of personal information. These principles are relevant by analogy to compulsory genetic testing and the protection of individual biological information.

3. District Registrar and Collector v. Canara Bank (2005)

The Supreme Court examined privacy protections relating to access to private documents and records.

Legal significance: The judgment reinforces the principle that confidential personal information should not be accessed or disclosed without appropriate legal justification. This principle is relevant to protecting genetic records maintained by hospitals, laboratories, and insurance companies.

4. LIC of India v. Consumer Education and Research Centre (1995)

The Supreme Court considered insurance practices in the context of constitutional fairness and reasonableness.

Legal significance: The judgment highlights the importance of fair insurance arrangements and protection against unreasonable conditions. Its principles are relevant when evaluating underwriting restrictions that may unfairly disadvantage individuals because of genetic characteristics.

5. Maneka Gandhi v. Union of India (1978)

The Supreme Court expanded the interpretation of Article 21 and established that procedures affecting personal liberty must be fair, just, and reasonable.

Legal significance: The judgment provides a broader constitutional foundation for protecting personal autonomy and preventing arbitrary action. These principles are relevant to the development of fair genetic underwriting practices.

Note: These judgments establish broader constitutional, privacy, and insurance fairness principles. They do not directly decide the legality of genetic underwriting restrictions in India.

International legal developments

Several international frameworks provide important guidance concerning genetic discrimination.

1. Genetic Information Nondiscrimination Act, 2008 (United States)

The Genetic Information Nondiscrimination Act (GINA) prohibits certain forms of genetic discrimination in health insurance and employment.

It generally restricts health insurers from using genetic information to determine eligibility, premiums, or contribution amounts.

However, GINA does not generally extend the same protections to life, disability, or long-term care insurance.

2. UNESCO Universal Declaration on the Human Genome and Human Rights, 1997

The declaration recognises the importance of human dignity and the protection of individuals against discrimination based on genetic characteristics.

It provides an important ethical foundation for regulating genetic information.

3. Council of Europe's Oviedo Convention, 1997

The Convention on Human Rights and Biomedicine establishes protections concerning human dignity, genetic testing, and discrimination.

Article 11 prohibits discrimination against a person on grounds of their genetic heritage.

These international developments demonstrate the growing importance of legal restrictions on genetic discrimination in insurance and healthcare.

Challenges in implementing genetic underwriting restrictions

Several challenges affect the implementation of effective genetic underwriting regulations.

Scientific uncertainty: Genetic predisposition does not necessarily establish that a person will develop a disease.

Lack of specialised legislation: India does not have a dedicated comprehensive legal framework governing genetic discrimination in insurance.

Privacy concerns: Genetic information may reveal sensitive information about multiple family members.

Actuarial difficulties: Insurers may find it difficult to establish reliable correlations between particular genetic variations and future insurance risks.

International differences: Genetic discrimination protections vary significantly between countries.

Technological developments: Advances in whole-genome sequencing and predictive analytics create new underwriting challenges.

Recommendations for stronger legal protection

A comprehensive genetic underwriting framework should include the following safeguards:

Prohibit arbitrary rejection of insurance applications based solely on genetic susceptibility.

Establish clear limitations on compulsory genetic testing.

Require scientifically reliable evidence before genetic information influences underwriting.

Protect confidential genetic records from unauthorised disclosure.

Establish transparent procedures for challenging genetic-risk classifications.

Develop specific regulatory standards governing AI-based genetic underwriting.

Introduce stronger protections for individuals who undergo voluntary genetic testing for preventive healthcare.

Conclusion

Insurance underwriting restrictions on genetics represent an important development in the relationship between biotechnology, insurance regulation, privacy, and human rights. Genetic information can improve medical understanding and preventive healthcare, but its misuse in insurance underwriting may create discrimination against individuals who have not developed any associated medical condition.

In India, constitutional protections under Articles 14 and 21, the Digital Personal Data Protection Act, 2023, the Insurance Act, 1938, and applicable IRDAI regulations provide important foundations for addressing these concerns.

Judicial decisions such as Puttaswamy, Selvi, and LIC of India v. Consumer Education and Research Centre establish relevant principles concerning privacy, autonomy, and insurance fairness. India would benefit from a dedicated legal framework restricting unjustified genetic discrimination and ensuring that insurance underwriting remains transparent, scientifically reliable, and consistent with individual rights.